This is consistent with the observation that ARCNM patients with BIN1 mutations predominantly display a proximal muscle weakness (Table 1), whereas ADCNM patients with DNM2 mutations rather present involvement of the distal muscles [17]. The gene discussed is DNM2; the disease is autosomal dominant centronuclear myopathy.